Cardiac Arrhythmia Monitoring Devices Market Report 2025

The cardiac arrhythmia monitoring devices market size has grown strongly in recent years. It will grow from $7.83 billion in 2024 to $8.43 billion in 2025 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to increased lifestyle-related risk factors, globalization of healthcare services, patient preference for home-based monitoring, awareness and screening programs, rising incidence of cardiovascular diseases,.

The cardiac arrhythmia monitoring devices market size is expected to see strong growth in the next few years. It will grow to $12.09 billion in 2029 at a compound annual growth rate (CAGR) of 9.4%. The growth in the forecast period can be attributed to expansion of telehealth services, focus on continuous monitoring, development of smart clothing for monitoring, focus on early intervention, focus on user-friendly device design, patient empowerment and engagement. Major trends in the forecast period include rise in wearable technologies, integration of artificial intelligence (ai), continuous ECG monitoring devices, miniaturization and portability, smartphone connectivity and apps, long-term monitoring solutions, innovations in implantable devices.

The anticipated rise in cardiovascular diseases is poised to drive the expansion of the cardiac arrhythmia monitoring devices market. Cardiovascular diseases encompass a range of conditions affecting the heart and blood vessels. In this context, cardiac arrhythmia monitoring devices play a crucial role in event monitoring, tracking the electrical activity of a patient's heart rhythm and detecting or assessing the risk of irregular heartbeats (arrhythmias). For example, projections by HMP Global in April 2023 indicate an expected increase in the prevalence of peripheral arterial disease in the US to 23.8 million by 2030, up from 21 million in 2020. This underscores the growth of the cardiac arrhythmia monitoring devices market driven by the escalating prevalence of cardiovascular diseases.

The rise of telehealth and telemedicine is anticipated to drive the growth of cardiac arrhythmia monitoring devices in the near future. Telehealth refers to utilizing telecommunications technology to deliver a wide array of healthcare services and information remotely, while telemedicine specifically focuses on remote clinical consultations and healthcare delivery. As remote healthcare services become more prevalent, there is a growing demand for wearable and portable monitoring devices that allow patients to continuously monitor their cardiac arrhythmias from home. The integration of telehealth with these monitoring devices meets the increasing need for remote patient management, particularly for those with chronic heart conditions, leading to improved diagnostic capabilities and enhanced overall healthcare outcomes. For example, in July 2023, Now Health International, a China-based medical insurance provider, reported a 12% increase in telemedicine adoption among individuals over 55 and a 13% rise among people living in rural areas. Thus, the expansion of telehealth and telemedicine is significantly contributing to the growth of the cardiac arrhythmia monitoring devices market.

Major companies in the cardiac arrhythmia monitoring devices market are concentrating on developing innovative solutions, such as advanced cardiac monitoring products, to enhance patient diagnostics and improve arrhythmia detection accuracy. These cardiac monitoring products are medical devices or systems designed to continuously or intermittently track the heart's electrical activity and overall function. For example, in January 2023, UltraLinQ, a US-based medical technology manufacturer, unveiled a new cardiac monitoring product at the Arab Health exhibition. The UltraLinQ system provides continuous heart rhythm monitoring for up to seven days, significantly increasing arrhythmia detection rates from 45% to nearly 97% compared to traditional Holter monitors, which capture data for only 24 hours. This system employs disposable, single-use wearable biosensors that enable patients to engage in daily activities like exercising, sleeping, and showering without the hassle of wires. Certified cardiac technicians can generate Holter reports within 36 hours, ensuring timely insights into heart health. Furthermore, UltraLinQ’s cloud-based platform allows healthcare providers to access medical images and data from any location, enhancing flexibility in patient care.

Major companies in the cardiac arrhythmia monitoring devices market are strategically developing new insertable cardiac monitoring systems to solidify their market positions. These small, implantable devices continuously monitor and record the heart's electrical activity, providing long-term diagnostic data for detecting cardiac arrhythmias and other cardiovascular conditions. In October 2023, Boston Scientific Corporation launched the LUX-Dx II+ Insertable Cardiac Monitor System, featuring dual-stage algorithms for detecting and verifying potential arrhythmias. The device prioritizes enhanced diagnostic capabilities, rejecting false positives and irrelevant episodes, and offers convenient remote monitoring through a downloadable app for patients.

In May 2024, WearLinq, a US-based digital healthcare company, acquired AMI Cardiac Monitoring for an undisclosed amount. This acquisition is intended to significantly enhance WearLinq's capacity to deliver clinical services. AMI Cardiac Monitoring is a US-based independent diagnostic testing facility (IDTF) that specializes in providing cardiac arrhythmia monitoring devices for patients seeking reliable assurance regarding their heart health.

Major companies operating in the cardiac arrhythmia monitoring devices market are AliveCor Inc., Biotronik SE & Co. KG, General Electric Company, iRhythm Technologies Inc., Koninklijke Philips N.V., Medtronic PLC, Nihon Kohden Corporation, Smart Solutions Technologies S.L., Abbott Laboratories, OSI Systems Inc., Hill-Rom Holdings Inc., Applied Cardiac System Diagnostics Inc., Biotricity Inc., Boston Scientific Corporation, Medicalgorithmics S.A., Siemens AG, Edwards Lifescience Corporation, LivaNova PLC, Phoenix Heart Center, Fukuda Denshi Co. Ltd., Royal Philips, NUUBO SMART SOLUTIONS S.L, Cardiac Insight Inc., CardioComm Solutions Inc., Vascular Solutions Inc., Johnson & Johnson Services Inc., MicroPort Scientific Corporation, Osypka AG, AtaCor Medical, Spacelabs Healthcare.

North America was the largest region in the cardiac arrhythmia monitoring devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the cardiac arrhythmia monitoring devices market report during the forecast period. The regions covered in the cardiac arrhythmia monitoring devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the cardiac arrhythmia monitoring devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cardiac arrhythmia monitoring device serves as a tool for the continuous monitoring of irregular heartbeats, specifically addressing the condition of arrhythmia.

The primary categories of cardiac arrhythmia monitoring devices encompass various types, including standards in ambulatory cardiac monitoring, patient- and event-activated intermittent recorders, external loop recorders, pre-symptom memory loop cardiac event recorders, post-symptom event recorders, continuous real-time attended remote cardiac monitors, mobile cardiac outpatient telemetry systems, and vital signs transmitters like Bio Watch Medical. Standards in ambulatory cardiac monitoring involve the recording and detection of electrical activity in a patient's heart over extended periods. These devices, such as the Holter monitor, event recorder, mobile cardiac telemetry, implantable cardiac monitor, electrocardiogram (ECG) monitor, and others, play a crucial role in diagnosing arrhythmias, including irregular heart rhythms. These monitoring devices are utilized across diverse healthcare settings, including hospitals, clinics, diagnostic centers, ambulatory surgical centers, homecare settings, and other relevant facilities. They are instrumental in detecting conditions such as tachycardia, bradycardia, premature contractions, and others, contributing to comprehensive cardiac care.

The cardiac arrhythmia monitoring devices market research report is one of a series of new reports that provides cardiac arrhythmia monitoring devices market statistics, including cardiac arrhythmia monitoring devices industry global market size, regional shares, competitors with a cardiac arrhythmia monitoring devices market share, detailed cardiac arrhythmia monitoring devices market segments, market trends and opportunities, and any further data you may need to thrive in the cardiac arrhythmia monitoring devices industry. This cardiac arrhythmia monitoring devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cardiac arrhythmia monitoring devices market consists of sales of wireless holter monitors, post-event recorder patch recorders, autodetect recorders, implanted loop recorders, remote monitoring of pacemakers, implantable cardioverter-defibrillators, real-time telemetry devices, and insertable loop recorders. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.